These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2447961)

  • 1. CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain.
    Kaye WH; Gwirtsman HE; George DT; Jimerson DC; Ebert MH
    Biol Psychiatry; 1988 Jan; 23(1):102-5. PubMed ID: 2447961
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain.
    Mantzoros C; Flier JS; Lesem MD; Brewerton TD; Jimerson DC
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1845-51. PubMed ID: 9177394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in CNS monoamine metabolism in anorexia nervosa.
    Kaye WH; Ebert MH; Raleigh M; Lake R
    Arch Gen Psychiatry; 1984 Apr; 41(4):350-5. PubMed ID: 6200083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?
    Kaye WH; Gwirtsman HE; George DT; Ebert MH
    Arch Gen Psychiatry; 1991 Jun; 48(6):556-62. PubMed ID: 1710099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa.
    Kaye WH; Ebert MH; Gwirtsman HE; Weiss SR
    Am J Psychiatry; 1984 Dec; 141(12):1598-601. PubMed ID: 6209991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa.
    Lesem MD; Kaye WH; Bissette G; Jimerson DC; Nemeroff CB
    Biol Psychiatry; 1994 Jan; 35(1):48-53. PubMed ID: 8167204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF neurochemistry of women with anorexia nervosa and normal women.
    Gerner RH; Cohen DJ; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Shaywitz BA; Hare TA
    Am J Psychiatry; 1984 Nov; 141(11):1441-4. PubMed ID: 6208797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF cortisol in patients with depression, mania, or anorexia nervosa and in normal subjects.
    Gerner RH; Wilkins JN
    Am J Psychiatry; 1983 Jan; 140(1):92-4. PubMed ID: 6183982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid opioid activity in anorexia nervosa.
    Kaye WH; Pickar D; Naber D; Ebert MH
    Am J Psychiatry; 1982 May; 139(5):643-5. PubMed ID: 7072853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.
    Kaye WH; Berrettini WH; Gwirtsman HE; Chretien M; Gold PW; George DT; Jimerson DC; Ebert MH
    Life Sci; 1987 Nov; 41(18):2147-55. PubMed ID: 2823041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
    Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
    Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
    Demitrack MA; Lesem MD; Listwak SJ; Brandt HA; Jimerson DC; Gold PW
    Am J Psychiatry; 1990 Jul; 147(7):882-6. PubMed ID: 2356873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH; Gwirtsman HE; George DT; Ebert MH; Jimerson DC; Tomai TP; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior therapy of anorexia nervosa: effectiveness of activity as a reinforcer of weight gain.
    Blinder BJ; Freeman DM; Stunkard AJ
    Am J Psychiatry; 1970 Feb; 126(8):1093-8. PubMed ID: 5411363
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered cerebrospinal fluid amino acid pattern in the anorexia of aging: relationship with biogenic amine metabolism.
    Martinez M; Arnalich F; Vazquez JJ; Hernanz A
    Life Sci; 1993; 53(21):1643-50. PubMed ID: 7694027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of anorexia nervosa with behavior modification. Effectiveness of formula feeding and isolation.
    Halmi KA; Powers P; Cunningham S
    Arch Gen Psychiatry; 1975 Jan; 32(1):93-6. PubMed ID: 803365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures of serotonin metabolism in anorexia nervosa.
    Hassanyeh F; Marshall EF
    Acta Psychiatr Scand; 1991 Dec; 84(6):561-3. PubMed ID: 1724337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anorexia nervosa. Behavior therapy in a male patient].
    Larsen JK; Skovgård B
    Ugeskr Laeger; 1977 Jan; 140(1):18-9. PubMed ID: 601899
    [No Abstract]   [Full Text] [Related]  

  • 19. Behaviour therapy in anorexia nervosa.
    Eckert ED; Goldberg SC; Halmi KA; Casper RC; Davis JM
    Br J Psychiatry; 1979 Jan; 134():55-9. PubMed ID: 760924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyproheptadine in anorexia nervosa.
    Goldberg SC; Halmi KA; Eckert ED; Casper RC; Davis JM
    Br J Psychiatry; 1979 Jan; 134():67-70. PubMed ID: 367480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.